Management of patients with advanced prostate cancer : report of the Advanced Prostate Cancer Consensus Conference 2019

• Séquençage d’un panel de gènes impliqués dans la réparation homologue dans les cancers de la prostate métastatiques résistants à la castration..

In the later stage of the trial, if the bio- marker subgroup combination of a new patient belongs to one of the graduating biomarker signatures, the pa- tient will enter

Objective We aimed to evaluate the characteristics and clinical outcomes of patients who received their first treatment for metastatic castration-resistant prostate cancer (mCRPC)

T he purpose of this article is to describe the treatment options available for men with early stage prostate cancer: radical prostatectomy (RP), prostate brachy- therapy

OBJECTIVE To highlight the role of psychosocial variables in treat- ment decision making for patients with localized prostate cancer and how family physicians can be of most help

There  are  many  treatment  options  available  to  men  with  diagnoses  of  prostate  cancer,  depending  on  the  stage  of  disease  and  their  health 

• The number of new prostate cancer cases and deaths will almost double by 2030 in Latin America and the Caribbean if current trends continue.. Proportion of new cases

Th en, truthful family physicians will make sure their patients understand that aggressive screening and treatment of prostate cancer might, at best, prolong their lives a